It all started when…

It all started when PharmaNest set out to quantify fibrosis — not as a static scar, but as a living, evolving signature of tissue remodeling. From that vision came FibroNest™, a platform built to measure every collagen fiber, decode its structure, and translate microscopic architecture into actionable biomarkers for drug discovery and clinical care.

Then came FibroMAP™ — born from the need to go deeper, beyond quantification, into discovery. By mapping millions of fibers into phenotypic clusters, FibroMAP reveals the hidden histological patterns that connect preclinical and clinical fibrosis and through the discovery of fibrotypes, help stratify patients and their outcomes.

What truly defines PharmaNest, though, is not just technology, but collaboration. Every project begins with dialogue — listening to scientists, clinicians, and partners to understand their questions, their data, their vision. From early discovery teams to late-stage clinical developers, we co-design studies, interpret patterns together, and uncover new fibrosis phenotypes that guide translational insight.

That closeness — scientific partnership and customer intimacy — is how FibroNest and FibroMAP evolved: one fiber, one collaboration, one discovery at a time.

It began in 2018— a spark of curiosity, a handful of slides, the quiet hum of algorithms learning to see fibrosis differently. Within years, the sound of recognition grew louder — conference halls, journal pages, double-digit publication growth worldwide.